hepatitis C

Gilead Sciences, Inc. Sovaldi Generic Version To Now Sell For $10 In Bangladesh
Bidness Etc.
Mon, 03/9/15 - 08:37 am
Gilead Sciences
Bangladesh
Sovaldi
hepatitis C
generics
Is AbbVie (ABBV) Giving Up On Hepatitis C Market Due To Tough Competition From Gilead (GILD)?
Bidness Etc.
Sat, 03/7/15 - 11:07 am
AbbVie
hepatitis C
Gilead Sciences
JNJ
Pfizer
Novartis
Natco Pharma ties up with Gilead on hepatitis C drugs
Yahoo/Reuters
Mon, 03/2/15 - 08:09 am
Gilead Sciences
Natco
hepatitis C
India
Sovaldi
Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study
Yahoo/Reuters
Thu, 02/26/15 - 04:46 pm
Bristol-Myers Squibb
hepatitis C
HIV
daclatasvir
Gilead's hep C star Harvoni, BMS' cancer med Opdivo lead ranks of 'exciting' launches
Fierce Pharma Marketing
Thu, 02/26/15 - 10:23 am
Gilead Sciences
Harvoni
hepatitis C
Bristol-Myers Squibb
Opdivo
melanoma
lung cancer
Mylan, Gilead in deal for Hepatitis C medications in India
Bizjournals.com
Mon, 02/23/15 - 09:47 am
Mylan Labs
Gilead Sciences
India
hepatitis C
Sovaldi
Harvoni
Gilead Sciences: How Strong are Hepatitis-C Sales?
Barron's
Sat, 02/21/15 - 09:45 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Crown the new drug launch king: Gilead's Harvoni has knocked aside sister med Sovaldi
Fierce Pharma Marketing
Wed, 02/18/15 - 04:20 pm
Gilead Sciences
Harvoni
Sovaldi
hepatitis C
[video]2 Small Biotech Stocks Dreaming Big in Hepatitis C
Motley Fool
Mon, 02/16/15 - 10:15 am
hepatitis C
Regulus
Achillion
Gilead Sciences: Hepatitis-C Tracking at High End of Guidance, RBC Says
Barron's
Sat, 02/14/15 - 09:54 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead expects big increase in Europeans treated with hep C drug
Yahoo/Reuters
Wed, 02/11/15 - 09:50 am
Gilead Sciences
Europe
hepatitis C
Sovaldi
Harvoni
Gilead faces challenge to European patent on pricey hep C drug
Yahoo/Reuters
Tue, 02/10/15 - 10:21 am
Gilead Sciences
Europe
patents
hepatitis C
Sovaldi
Regulus slides after hep C contender's results underwhelm investors
Fierce Biotech
Mon, 02/9/15 - 08:30 am
Regulus
hepatitis C
RG-101
microRNA
Achillion HCV-1 regimen achieves 100% SVR12 at six weeks
Seeking Alpha
Mon, 02/9/15 - 08:26 am
Achillion
hepatitis C
ACH-3102
Gilead Sciences
Sovaldi
Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade
Barron's
Sat, 02/7/15 - 10:23 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C
Gilead's Harvoni Selected as Cigna Preferred Treatment for Hepatitis C Genotype 1
NASDAQ.com
Fri, 02/6/15 - 10:25 am
Gilead Sciences
Harvoni
Cigna
hepatitis C
No, the Gilead-AbbVie Price War Won’t Derail the Pharmaceutical Rally
Barron's
Fri, 02/6/15 - 10:30 am
Gilead
AbbVie
drug pricing
hepatitis C
Bigger drug discounts put question mark over Gilead's stellar run
Fortune
Wed, 02/4/15 - 10:18 am
Gilead Sciences
drug discounts
hepatitis C
Sovaldi
Harvoni
FDA yanks 'breakthrough' bragging rights to Merck's hep C combo
Fierce Biotech
Wed, 02/4/15 - 08:36 am
FDA
Merck
hepatitis C
grazoprevir
elbasvir
AbbVie Projects $3B Sales For HCV Cocktail, But Shares Fall 3%
Seeking Alpha
Mon, 02/2/15 - 03:28 pm
AbbVie
hepatitis C
Viekira Pak

Pages